Atlas Trials

A Trial of Apatinib and Adebrelimab in Combination With Chemotherapy in Patients With Unresectable ICC

Clinical trial NCT06925516 · RECRUITING

Trial details

NCT number
NCT06925516
Sponsor
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Intrahepatic Cholangiocarcinoma (Icc)
Start date
2025-04-25
Primary completion
2027-06-01
Enrollment
38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.